A novel immunoassay system based on the changes in the reflection of light, termed an optical immunoassay (OIA), was utilized to directly detect group A streptococcal (GAS) carbohydrate antigen from clinical specimens. In two studies, a total of 1,275 throat swabs were tested for the presence of this antigen with the Strep A OIA rapid detection system and the results were compared with those of standard culture methods. In both studies, the Strep A OIA yielded more positive results than plating of the throat swab onto a selective agar, Trypticase soy agar containing sheep blood, or an enriched broth. In one study, the sensitivity and specificity of Strep A OIA compared with those of the broth-enriched culture were 97.4 and 95.6%, respectively. In a second study a sensitivity of 98.9%o and a specificity of 98.6% were achieved. It was also shown that the carbohydrate antigen could be detected in the absence of viable GAS organisms. The Strep A OIA is an easily interpretable method and was shown to be more sensitive than routine culture methods for detecting GAS infections directly from throat swabs.
Trypticase soy agar containing sheep blood, or an enriched broth. In one study, the sensitivity and specificity of Strep A OIA compared with those of the broth-enriched culture were 97.4 and 95.6%, respectively. In a second study a sensitivity of 98.9%o and a specificity of 98.6% were achieved. It was also shown that the carbohydrate antigen could be detected in the absence of viable GAS organisms. The Strep A OIA is an easily interpretable method and was shown to be more sensitive than routine culture methods for detecting GAS infections directly from throat swabs.
Group A streptococci (GAS) are some of the most significant pathogens responsible for tonsillitis and pharyngitis in both children and young adults. Various methods, including clinical diagnosis and culture methods, have been used to diagnose GAS pharyngitis. It is difficult to clinically distinguish between streptococcal and nonstreptococcal pharyngitis, and most physicians tend to overestimate the likelihood of positive GAS cultures (19) . Early treatment of infection results in rapid resolution of the symptoms and helps prevent further complications such as acute rheumatic fever, acute glomerulonephritis, and streptococcal bacteremias (2) . Recently, there has been an increase in GAS bacteremia (23, 24) and in documented cases of acute rheumatic fever in a number of geographically distinct locations (3, 21) . It has been noted that accurate, early diagnosis and treatment of GAS pharyngitis not only can prevent further complications (6, 20) but also can shorten the duration of clinical illness and the transmission of disease and, in negative cases, eliminate unnecessary treatment with antibiotics. Thus, there exists a need for a rapid, reliable test for GAS to assist in early diagnosis of pharyngitis.
Over the past several years a large number of commercial products for the direct rapid detection of GAS from clinical specimens have been introduced. These procedures depend on the detection of a carbohydrate antigen specific for GAS. In general, many of the procedures employed by these commercial products are immunologic, using either a monoclonal or polyclonal anti-GAS carbohydrate antibody in a latex agglutination assay or enzyme immunoassay. Most (5, 11, 15, 25, 26) .
The direct visualization of an antibody bound to an immobilized antigen on a reflecting surface was originally described in 1938 by Shaffer and Dingle (22) . Others (1, 10, 18) . The concept behind these surface immunoassays is that the direct visualization of a second antigen layer applied to an existing monolayer results in changes in the reflective properties. In this study, we compared standard culture techniques for the detection of GAS with a novel, rapid, surface immunoassay termed optical immunoassay (OIA) to detect GAS carbohydrate antigen directly from clinical isolates.
MATERIALS AND METHODS
Two studies were performed to compare the Strep A OIA (BioStar, Inc., Boulder, Colo.) rapid detection system with culture on either streptococcus-selective agar or Trypticase soy agar containing 5% sheep blood (TSA). Both studies included the use of an enriched-broth culture. The study design for each method is shown in Fig. 1 performed by using the swab and following the manufacturer's package insert as described below.
A broth-enriched culture method was designed to confirm the presence of GAS. The pledgets (plugs separating the media and swabs in the transport tubes) were aseptically removed from the tubes, placed in Todd-Hewitt broth (THB) (BBL), and incubated for 24 h at 35°C. All specimens were subcultured by placing an aliquot of THB onto SSA. These plates were incubated for 24 to 48 h at 35°C in CO2. If growth patterns consistent with GAS were observed, colonies were selected and reisolated if necessary and their identification was confirmed by the latex agglutination assay (Wellcome Streptex).
(ii) Study 2: TSA culture and Strep A OUI. Study 2 followed the same protocol as study 1 except for the following: (i) swabs in transport medium were obtained from a large private physician's practice and a university student health center; (ii) all swabs were cultured at the site of origin prior to OIA; (iii) all sites used TSA (BBL) instead of SSA, and the physician's laboratory practice incubated the TSA cultures anaerobically; (iv) PathoDx Strep Typing Sera (Diagnostic Products Corp., Los Angeles, Calif.) was used as the serotyping kit for confirmation of positive cultures; and (v) only OIA-positive and culture/OIA-discrepant (OIApositive, agar-negative or OIA-negative, agar-positive) results, rather than all of the THB cultures, were subcultured to TSA. Subcultures from THB were incubated anaerobically (BBL GasPak).
Description of the OIA. OIA allows the direct visual detection of the physical change in thickness of thin films resulting from the binding reactions between antigens and antibodies. A color change is generated by the change in the reflection of light through the films formed on the optical substrate (Fig. 2) . The test surface has an affinity-purified anti-GAS polyclonal rabbit antibody attached to it. Light reflected through this series of thin films results in a gold color. The color change will not occur unless the thickness of the film is changed. When a liquid sample containing antigen is placed on the surface, binding occurs between the antigen and the immobilized antibody. When the sample is followed by a substrate, there is an increase in the thickness of the film. Once this reaction takes place, the optical path through the film is changed, causing the surface to appear purple (Fig. 2) . If the antigen is not present in the sample, no binding takes place and the original thickness remains unchanged so that the test surface retains its original gold color. This optical detection system provides a clear end point.
In the 8-min Strep A OIA, carbohydrate antigen is extracted from the swab with 0.3 M acetic acid (9) . Three drops of this solution are added to the extraction tubes provided in the kit. After a 2-min incubation, the solution is neutralized with 3 drops of 1.5 M MOPSO [3- No differences in the recovery of viability of GAS from Culturette swabs stored under moist versus dry environmental conditions were observed; therefore, the data are not discussed in this paper.
Strep A OIA detected GAS antigen on all inoculated swabs prior to exposure of the swabs to the environmental transport conditions. At 24, 48, and 72 h, GAS antigen was detected by Strep A OIA from 100% of the swabs for all study conditions. DISCUSSION All in vitro immunologic diagnostic tests to detect GAS, including Strep A OIA, require the binding of GAS antigen to a specific antibody. The Strep A OIA utilizes a direct visual detection of the immunological binding event by relying on the interaction of light with thin films on a silicon surface. Membrane-based assays have a relatively higher nonspecific binding that results in a reduction in sensitivity. Strep A OIA's combination of optical thin-film detection on a silicon crystal surface allows for a rapid method with an enhanced sensitivity without sacrificing specificity.
The reference culture method used to determine the sensitivity and specificity of any rapid test may affect the study results. The lack of a definitive method to use as a standard reference method for the detection of GAS from throat swabs adds to the problem. In both the SSA (study 1) and TSA (study 2) studies, the data collected support the results of other studies showing that conventional culturing methods are less sensitive than broth-enriched methods when culturing for GAS (5, 11) . Broth-enriched methods, however, are not widely used because of the added cost and turnaround time. Routine cultures using SSA and TSA compared with the broth-enriched cultures demonstrated sensitivities of 75.4 and 76.3%, respectively. Despite these findings, the throat culture is still used as the "gold standard" for GAS testing and considered to be more sensitive than most rapid methods (12, 16, 17, 21, 26 The absence of positive reactivity to upper respiratory pathogens in the specificity studies shows that the Strep A OIA is a highly specific test, as has been observed with other rapid detection methods (6, 7, 13, 25) . Compared with the reference broth-enriched method, specificities of 95.6% in study 1 There are over 30 million throat swabs processed for GAS annually in the United States (17) . However, the use of culture as a detection method for GAS has little impact on patient management (7 It has been postulated that the recurrence of rheumatic fever may be linked to the misuse of current rapid assays. This may have occurred because the physicians neglected to have a culture performed on negative samples after obtaining results on a less sensitive rapid assay. The Strep A OIA is the first GAS rapid antigen assay available with a demonstrated performance combining excellent specificity with a sensitivity equivalent to that of an enriched broth culture and better than those of the conventional culture methods used in this study (SSA and TSA). This development eliminates the need to perform confirmatory cultures of negative samples and can offer a significant enhancement in patient care while reducing the cost of patient management.
